Esperion Therapeutics, Inc. 4
4 · Esperion Therapeutics, Inc. · Filed Jan 5, 2016
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2016-01-04+15,000→ 15,000 totalExercise: $21.65Exp: 2026-01-04→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 4, 2016.